Selecting the correct diluent should always be based on the peptide's documented stability characteristics and the objectives of the specific experiment
This means that patients can experience faster and more noticeable results with injections, making them ideal for those who need an immediate impact
BPC-157 accelerates healing but cannot regenerate severely degenerated structures, overcome major structural abnormalities, or replace the need for rehabilitation
While peptide therapy may possess significant therapeutic and regenerative potential, it is critical that orthopedic and sports medicine providers understand the current lack of evidence to support the clinical use of these peptides, the authors concluded
In 2023, the FDA placed approximately 1719 peptides on the Category 2 restricted list citing safety concerns: potential carcinogenicity, immunogenicity risk, organ toxicity, and a lack of clinical trial data in humans
This is a separate and still investigational line of research rather than an established use, and it should not be confused with the fat-loss mechanism that the bulk of the clinical work has focused on
